Abstract

Background: Phyllanthus niruri is an annual plant that is widely used in Asia and Africa traditionally for the treatment of various ailments such as Jaundice, Asthma, Hepatitis, Flu, Dropsy, Diabetes, Malaria, Hemorrhages, Diarrhea, and Anaemia. Objective: This study evaluates the haemotological and biochemical parameters of P. niruri in 2,4-dinitrophenylhydrazine-induced haemolytic anaemia in Wister rats for possible antianemic potential. Methods: This study evaluates the Antianaemic effect of the plant extract based on haemotological and biochemical parameters and body weight in 2,4-dinitrophenylhydrazine-induced haemolytic anaemia in Wister rats. Extract was administered in three different doses (250, 500, and 1000 mg/ kg b.wt) of the plant extract and folic acid was used as a positive control. Haematological parameters such as PCV, Hb, RBC, WBC, MCV, MCH, Reticulocyte count were evaluated. Oxidative stress markers (MAD, catalase and SOD) and bilirubin (total and unconjugated) were also analyzed. Results: The results showed that, PCV, Hb, RBC concentration increased significantly (P 0.05) effect was observed at a dose of 250 mg/kg b.wt. WBC, MCV, MHC and reticulocytes was decreased significantly (P 0.05) effect was observed at a dose of 250 mg/kg b.wt. A significant (P 0.05) effect was observed at a dose of 250 mg/kg b.wt. Conclusion: The results suggest that the aqueous whole plant extract of P. niruri plant is relatively safe and possesses a significant anti-anaemic property; therefore, it may be a potential lead in the discovery of drug for treatment of heamolytic anaemia.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.